Services Summary Description. Subject to the terms and conditions of this Agreement (including Section 2 hereof), Provider shall provide the following Services to Recipient. The agreement signed on 29 May 2007 entered into by Bristol-Myers Squibb (Phils.) Inc. and Hizon Laboratories for the scope of services benefiting the Recipient’s business shall be continued by the Provider until 31 December 2009. The agreement signed on 23 September 1992 entered into by Bristol-Myers Squibb (Phils.) Inc. and Hizon Laboratories exclusively benefiting the Recipient’s business shall be continued by the Provider until 31 December 2009. The agreement signed on 9 November 1999 entered into by Bristol-Myers Squibb (Phils.) Inc. and InterPhil benefiting the Recipient’s business shall be continued by the Provider until 31 December 2009. The binding MOU dated 28 April 2004 and made between Bristol-Myers Squibb (Phils.) Inc. and Cardinal Health Australia 401 Pty Ltd benefiting the Recipient’s business shall be continued by the Provider until 31 December 2009. While Provider will continue the above mentioned TPM contracts, the Recipient shall be responsible for managing the operational requirements. The Recipient shall use best efforts to ensure that after 30 September 2009 no transactions are entered under any of the above agreements. The Recipient may require the Provider to terminate or assign the aforementioned contracts. Provider shall agree to take such action as may be required to effect the termination or transfer in compliance with applicable Laws. The Provider, however, shall not be held responsible for any legal action that could potentially arise upon termination of the above mentioned TPM contracts.
Appears in 2 contracts
Sources: Transitional Services Agreement (Mead Johnson Nutrition Co), Transitional Services Agreement (Mead Johnson Nutrition Co)